Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2003

01-12-2003

Predictors of HIV Sexual Risk Behaviors in a Community Sample of Injection Drug-Using Men and Women

Authors: Anton M. Somlai, Jeffrey A. Kelly, Timothy L. McAuliffe, Kate Ksobiech, Kristin L. Hackl

Published in: AIDS and Behavior | Issue 4/2003

Login to get access
Metadata
Title
Predictors of HIV Sexual Risk Behaviors in a Community Sample of Injection Drug-Using Men and Women
Authors
Anton M. Somlai
Jeffrey A. Kelly
Timothy L. McAuliffe
Kate Ksobiech
Kristin L. Hackl
Publication date
01-12-2003
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
AIDS and Behavior / Issue 4/2003
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1023/B:AIBE.0000004730.62934.ed

Other articles of this Issue 4/2003

AIDS and Behavior 4/2003 Go to the issue

OriginalPaper

Perspectives Related to the Potential Use of Vaginal Microbicides Among Drug-Involved Women: Focus Groups in Three Cities in the United States and Puerto Rico

OriginalPaper

Why HIV Infections Have Increased Among Men Who Have Sex with Men and What to Do About It: Findings from California Focus Groups

OriginalPaper

Factors Associated with Psychological Distress in Urban Mothers with Late-Stage HIV/AIDS

OriginalPaper

The Life Priorities of HIV-Seropositive Injection Drug Users: Findings from a Community-Based Sample

OriginalPaper

Self-Perceived Responsibility of HIV-Seropositive Men Who Have Sex with Men for Preventing HIV Transmission

OriginalPaper

The Utility of the PRECEDE Model in Predicting HIV Risk Behaviors Among Puerto Rican Injection Drug Users
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits